Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
03 2020
Historique:
received: 15 07 2019
revised: 30 10 2019
accepted: 30 10 2019
pubmed: 11 11 2019
medline: 24 6 2021
entrez: 10 11 2019
Statut: ppublish

Résumé

Natural killer (NK) cells expressing killer cell immunoglobulin-like receptors (KIRs) can recognize specific HLA class I molecules as their ligands. By studying a large Japanese transplant registry, we compared transplant outcomes between patients heterozygous for HLA-C

Identifiants

pubmed: 31704471
pii: S1083-8791(19)30714-1
doi: 10.1016/j.bbmt.2019.10.032
pii:
doi:

Substances chimiques

HLA-C Antigens 0
Receptors, KIR 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-437

Informations de copyright

Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Nobuyoshi Arima (N)

Department of Hematology, Shinko Hospital, Kobe, Japan; Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan. Electronic address: arima.nobuyoshi@shinkohp.or.jp.

Junya Kanda (J)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Toshio Yabe (T)

Laboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Yasuo Morishima (Y)

Central Japan Cord Blood Bank, Seto, Japan.

Junji Tanaka (J)

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Shinichi Kako (S)

Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

Hirotoshi Sakaguchi (H)

Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross, Nagoya First Hospital, Nagoya, Japan.

Motohiro Kato (M)

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Kazuteru Ohashi (K)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Yukiyasu Ozawa (Y)

Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Takahiro Fukuda (T)

Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.

Shuichi Ota (S)

Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.

Takayoshi Tachibana (T)

Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.

Makoto Onizuka (M)

Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.

Tatsuo Ichinohe (T)

Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Yoshiko Atsuta (Y)

The Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshinobu Kanda (Y)

Division of Hematology, Jichi Medical University, Shimotsuke, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH